Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03388138 · ClinicalTrials.gov registry record · Phase 2
Clinical Evaluation of Etafilcon A With Ketotifen
A Phase 2 study, sponsored by Johnson & Johnson Vision Care.
- Completed
- Registry status
- Phase 2
- Development phase
- 143
- Enrollment target
NCT03388138 is a Phase 2 study that has completed, run by Johnson & Johnson Vision Care. The registered enrollment target is 143 participants.
The verdict
NCT03388138, a Phase 2 study, has completed, sponsored by Johnson & Johnson Vision Care.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 143 participants
- Enrollment target
Study Summary
This clinical study is a randomized, double-masked, bilateral, controlled, two-arm parallel group, multi-site, 1-Week, 2-visit dispensing study. Subjects between the ages of 18-40 will be randomized into a placebo arm or an investigational K-Lens arm.
Interventions
- COMBINATION_PRODUCT etafilcon A with ketotifen
- DEVICE 1-Day ACUVUE
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 143 participants |
| Start Date | 2017-12-06 |
| Est. Completion | 2018-02-09 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03388138
The ClinicalTrials.gov registry entry for NCT03388138 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 143 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johnson & Johnson Vision Care, which has 142 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which etafilcon A with ketotifen is the first listed.
NCT03388138 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03388138 about?
NCT03388138 is a clinical study titled "Clinical Evaluation of Etafilcon A With Ketotifen". This clinical study is a randomized, double-masked, bilateral, controlled, two-arm parallel group, multi-site, 1-Week, 2-visit dispensing study. Subjects between the ages of 18-40 will be randomized into a placebo arm or an investigational K-Lens arm.
What is the current status of trial NCT03388138?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 143 participants. The study started on 2017-12-06. Estimated completion is 2018-02-09.
What interventions are being tested in trial NCT03388138?
The interventions under investigation include: etafilcon A with ketotifen (COMBINATION_PRODUCT), 1-Day ACUVUE (DEVICE).
Who is sponsoring clinical trial NCT03388138?
This trial is sponsored by Johnson & Johnson Vision Care, which has 142 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.